FDA Approved: XHANCE — Original Application (OptiNose US, Inc.)

View source ↗

Summary

The FDA approved XHANCE, a new intranasal spray formulation of fluticasone propionate from OptiNose US, Inc., under an original NDA for treatment of nasal sympt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• XHANCE (Fluticasone propionate)

Snippet

ORIG AP for XHANCE (FLUTICASONE PROPIONATE)